Another CAR-T Impresses in Follicular Lymphoma Complete responses in 66% of patients with relapsed or refractory disease Jun 08, 2021
BPAs Cut Fracture Risk in Metastatic Prostate Cancer Those receiving enzalutamide with and without radium-223 saw benefits in updated safety analysis Jun 08, 2021
Acalabrutinib Offers Less Wear and Tear on the Heart in CLL Patients BTK inhibitor had less cardiotoxicity than ibrutinib, but similar efficacy Jun 07, 2021
Adjuvant Anti-PD-1 Misses on OS in High-Risk Melanoma But pembrolizumab topped active controls for relapse-free survival Jun 07, 2021
Combination Shows Promise in Post-Osimertinib Lung Cancer Responses in 36% with amivantamab-lazertinib, 47% with EGFR/MET resistance Jun 06, 2021
Novel CDK 4/6 Inhibitor Proves Mettle in HR+/HER2- Advanced Breast Cancer Dalpiciclib may be a new treatment option; palbociclib and ribociclib continue to shine Jun 06, 2021
Perioperative Chemo Enough in Esophageal Cancer? MAGIC/FLOT regimens yielded similar overall survival to multimodal CROSS regimen Jun 06, 2021
CAR-T Drives High Response in Relapsed/Refractory ALL ZUMA-3 study shows brexucabtagene autoleucel offers long-term clinical benefit Jun 06, 2021
Antibody-Drug Conjugate Active in Resistant Lung Cancer Responses in 39% of EGFR inhibitor-resistant patients with patritumab deruxtecan Jun 05, 2021
Chemoimmunotherapy Tied to Better Outcomes in Advanced NSCLC PD-L1 status and age play key roles in success of combined regimen versus immunotherapy alone Jun 05, 2021
Combination Therapy Achieves High Response in Ph+ ALL Ponatinib-blinatumomab offers promising regimen in frontline and relapse/refractory disease Jun 05, 2021
Small PFS Bump in Synovial Sarcoma With Novel Drug But questions raised over control arm and whether improvement represents a meaningful benefit Jun 05, 2021
Radioligand Therapy Boosts Survival in Metastatic CRPC PSMA-directed agent improved overall survival by median 4 months Jun 04, 2021
Adding Chemo to Standard Care No Help for Cervical Cancer Similar OS, PFS, and patterns of recurrence, with more toxicity Jun 04, 2021
With Supplements, ADT in Prostate Cancer of Little Threat to Bone Density Study suggests calcium/vitamin D alone sufficient for long-duration therapy Jun 03, 2021
PD-1 Inhibitor Shows Benefit in Nasopharyngeal Cancer Toripalimab plus first-line chemo improved survival in recurrent/metastatic disease Jun 03, 2021
Olaparib Wins in Early BRCA-Mutant Breast Cancer First trial to show adjuvant PARP inhibitor benefit inBRCA mutation carriers Jun 03, 2021
Survival Boost With First-Line Immunotherapy for Esophageal Cancer Nivolumab plus ipilimumab or chemo offers new option for advanced, metastatic disease Jun 03, 2021
'A Quantum Leap Forward': Potential New Standard in High-Risk RCC Adjuvant immunotherapy led to 32% reduction in the risk of recurrence, positive trend in OS Jun 03, 2021
Charles Grodin's Death From Multiple Myeloma A look at the beloved actor's highly treatable but rarely curable disease Jun 02, 2021
First-Line Chemo Plus Immunotherapy Falls Short in Bladder Cancer Adding pembrolizumab to cisplatin-based chemotherapy did not improve survival outcomes Jun 02, 2021
Radiation Speeds Up Biological Aging in Head and Neck Cancer Epigenetic age acceleration linked with greater inflammation and fatigue Jun 01, 2021
Bevacizumab Misses Mark in Untreated Metastatic Bladder Cancer No improvement in overall survival when added to cisplatin-containing chemotherapy Jun 01, 2021
Drug to Delay T1D Gets Tepid Endorsement by FDA Advisors Feelings mixed on safety and efficacy evidence for novel biologic May 28, 2021
Hospital at Home May Reduce Hospitalization, Costs for Cancer Patients Study demonstrated efficacy, cost-effectiveness of providing hospital-level services at home May 26, 2021
Lymph Node Findings on PET: Cancer or COVID Vaccine? Post-jab radiotracer uptake "could prompt unnecessary biopsies and treatments" May 26, 2021
Bad Day Sunshine: Benzene Found in Many Sun Care Products Valisure also detected the carcinogen in hand sanitizers earlier this year May 26, 2021
Potassium Acid Blocker No Better Than PPI for Artificial Gastric Ulcers Small Japanese trial found similar outcomes with both drugs May 25, 2021
Op-Ed: A Door Opens to Transform Cancer Care Incoming CMS Administrator Chiquita Brooks-LaSure brings hope to the cancer community May 25, 2021
Family Alleges Profit Motives Played Role in 3-Year-Old's Death Parents charge care delays for child with hydrocephalus were tied to arrangements for star doctor May 25, 2021
Test Can Predict Death Risk With Adrenal Tumors This can help guide need for surgical intervention, researcher says May 24, 2021
Ovarian Cancer Screening Trial Still Sees No Death Reduction Researchers "disappointed" by long-term results of U.K. study of 200,000 postmenopausal women May 22, 2021
RET Fusion Inhibitor Active Beyond Lung, Thyroid Cancers Responses to selpercatinib in almost half of tumors outside approved indications May 21, 2021
Anti-PD-L1 Plus SBRT Enhances Major Responses in Early NSCLC Neoadjuvant combo needs to be validated in a larger randomized trial May 20, 2021
Vaccination, Screening Succeeds in Cervical and Prostate Cancers Cervical cancer rates on the decline; PSA testing benefits younger Black men May 19, 2021
PD-L1 Inhibitor Thwarts Recurrence in Early Lung Cancer Risk of death, recurrence 34% lower with atezolizumab after surgery and chemo May 19, 2021
Novel Immunotherapy Boosts Melanoma Outcomes Adding LAG-3 checkpoint inhibitor to nivolumab extended PFS in patients with advanced disease May 19, 2021
Breast Cancer and MS: New Data Shed Light on Survival Study compares breast cancer patients with and without MS May 19, 2021
CHS Sues Thousands of Patients; Hospital Parking Fees Under Fire; Trump-Era Emails This past week in healthcare investigations May 19, 2021
Imiquimod Spurs Regression of High-Grade Cervical Lesions Application of topical cream followed by LEEP benefited patients more than LEEP alone May 17, 2021
